Effect of rifampicin on the mouse hepatic mixed-function oxidase system.
D000818:Animals; D001571:Benzoflavones / Q000494:pharmacology; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008862:Microsomes, Liver / Q000187:drug effects / Q000201:enzymology*; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D009251:NADPH-Ferrihemoprotein Reductase / Q000378:metabolism; D010088:Oxidoreductases / Q000378:metabolism*; D010634:Phenobarbital / Q000494:pharmacology; D011285:Pregnenolone Carbonitrile / Q000494:pharmacology; D011335:Proadifen / Q000494:pharmacology; D012293:Rifampin / Q000494:pharmacology*; D012969:Sodium Fluoride / Q000494:pharmacology; D019324:beta-Naphthoflavone
D001571:Benzoflavones; D011285:Pregnenolone Carbonitrile; D019324:beta-Naphthoflavone; D012969:Sodium Fluoride; D003577:Cytochrome P-450 Enzyme System; D011335:Proadifen; D006899:Mixed Function Oxygenases; D010088:Oxidoreductases; D009251:NADPH-Ferrihemoprotein Reductase; D012293:Rifampin; D010634:Phenobarbital